Covered in this patent is the use of the cytokine currently named M-CSF, for the expansion of hematopoietic stem cells and their differentiation along the myeloid lineage. Mice that are knocked out for M-CSF do not have functional macrophages, but also do not have tumor associated angiogenesis.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.